# 4D Molecular Therapeutics, Inc.: Form 8-K, filed Feb 10, 2025

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2025-02-10
- Accepted by EDGAR: Feb 10, 2025, 13:37 ET
- Period: 2025-02-08
- Accession: 0000950170-25-016708
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000095017025016708/fdmt-20250208.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000095017025016708/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000095017025016708/fdmt-20250208.htm

Filed Feb 10, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-016708. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.